Skip To Main Content
Chijun Meng on Muck Rack

Chijun Meng

As seen in: Royal Society of Chemistry
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Chijun

Contact Chijun, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Nanozymes in cancer immunotherapy: metabolic disruption and therapeutic synergy

|
By Xiangrui Xu, Yaowen Zhang, Wenzhuo Zheng, Chijun Meng
| Royal Society of Chemistry Verified
Nanozymes in cancer immunotherapy: metabolic disruption and therapeutic synergy Over the past decade, there has been a growing emphasis on investigating the role of immunotherapy in cancer treatment. However, it faces challenges such as limited efficacy, a diminished response rate, and serious adverse effects. Nanozymes, a subset of nanomaterials, demonstrate boundless potential in cancer catalytic therapy for their tunable activity, enhanced stability, and cost-effectiveness.
Open in Who Shared Issue with article?
See all 1 articles